674767100	674767100	CD	B-NP	O
|	|	NN	I-NP	O
BLHC	BLHC	NN	I-NP	O
|	|	NN	I-NP	O
68481479	68481479	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9196390	9196390	CD	B-NP	O
|	|	CC	I-NP	O
5/19/2006	5/19/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
S/P	S/P	NN	I-NP	I-protein
Rt	Rt	NN	I-NP	I-protein
TKR	TKR	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/2/2006	10/2/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/5/2006	7/5/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-NP	O
LIEBERMAN	LIEBERMAN	NN	I-NP	O
,	,	,	O	O
THERON	THERON	NNP	B-NP	O
JEWELL	JEWELL	NNP	I-NP	O
633-06-62-8	633-06-62-8	CD	I-NP	O
Donpool	Donpool	NNP	I-NP	O
Ave.	Ave.	NNP	I-NP	O
,	,	,	O	O
West	West	NNP	B-NP	O
Tul	Tul	NNP	I-NP	O
Jo	Jo	NNP	I-NP	O
,	,	,	O	O
Florida	Florida	NNP	B-NP	O
39640	39640	CD	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
ORT	ORT	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
3/6/06	3/6/06	CD	B-NP	O
AT	AT	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
PUCKHABER	PUCKHABER	NN	B-NP	O
,	,	,	O	O
TRUMAN	TRUMAN	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DISPOSITION	DISPOSITION	NNP	I-NP	O
:	:	:	O	O
Rehabilitation	Rehabilitation	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
650	650	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q4H	Q4H	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
3/10	3/10	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
,	,	,	O	O
Headache	Headache	NNP	B-NP	O
,	,	,	O	O
Other	Other	NNP	B-NP	O
:	:	:	O	O
fever	fever	NN	B-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
Instructions	Instruction	NNS	B-NP	O
:	:	:	O	O
Do	Do	VBP	B-VP	O
not	not	RB	I-VP	O
exceed	exceed	VB	I-VP	O
4000mg	4000mg	NN	B-NP	O
in	in	IN	B-PP	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

CALCIUM	CALCIUM	NN	B-NP	O
CARBONATE	CARBONATE	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
500	500	CD	I-NP	O
MG	MG	NN	I-NP	O
ELEMENTAL	ELEMENTAL	NN	I-NP	O
CA	CA	NN	I-NP	O
+	+	SYM	B-VP	O
+	+	SYM	B-NP	O
-RRB-	-RRB-	SYM	O	B-protein
500	500	CD	B-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
DAILY	DAILY	NN	I-NP	I-protein
COLACE	COLACE	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
DOCUSATE	DOCUSATE	NNP	I-NP	I-protein
SODIUM	SODIUM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
FAMOTIDINE	FAMOTIDINE	NNP	I-NP	I-protein
20	20	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
REGULAR	REGULAR	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneously	subcutaneously	RB	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
SC	SC	NN	I-NP	B-protein
Q6H	Q6H	NN	I-NP	I-protein
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
125	125	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
125-150	125-150	CD	B-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
151-200	151-200	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	B-protein
Call	Call	NN	I-NP	I-protein
HO	HO	NN	I-NP	I-protein
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
400	400	CD	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NN	I-NP	O
SODIUM	SODIUM	NN	I-NP	O
50	50	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/23/06	8/23/06	CD	B-NP	O
by	by	IN	B-PP	O
SIMKULET	SIMKULET	NNP	B-NP	O
,	,	,	O	O
SONNY	SONNY	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
MVI	MVI	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
MULTIVITAMINS	MULTIVITAMINS	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
8/23/06	8/23/06	CD	B-NP	O
by	by	IN	B-PP	O
BLACOCK	BLACOCK	NN	B-NP	O
,	,	,	O	O
DEVIN	DEVIN	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ZOCOR	ZOCOR	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
437553459	437553459	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
OXYCODONE	OXYCODONE	NN	B-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q6H	Q6H	NN	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
3/10	3/10	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
HOLD	HOLD	NNP	I-NP	O
IF	IF	NNP	I-NP	O
:	:	:	O	O
somnolent	somnolent	JJ	B-NP	O
,	,	,	I-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
changes	change	NNS	I-NP	O
COUMADIN	COUMADIN	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
6	6	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
x1	x1	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
Dose	Dose	NN	B-NP	O
for	for	IN	B-PP	O
1/7/06	1/7/06	CD	B-NP	O
.	.	.	O	O

Monitor	Monitor	IN	B-PP	O
a	a	DT	B-NP	O
daily	daily	JJ	I-NP	O
PT/INR	PT/INR	NN	I-NP	B-protein
in	in	IN	B-PP	O
rehab	rehab	NN	B-NP	O
and	and	CC	O	O
adjust	adjust	VBP	B-VP	O
the	the	DT	B-NP	O
dose	dose	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
goal	goal	NN	I-NP	O
INR	INR	NN	I-NP	O
of	of	IN	B-PP	O
1.5-2	1.5-2	CD	B-NP	O
.5	.5	CD	I-NP	O
;	;	:	O	O
DVT	DVT	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
is	be	VBZ	B-VP	O
planned	plan	VBN	I-VP	O
X	X	SYM	B-NP	O
3	3	CD	I-NP	O
weeks	week	NNS	I-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
No	No	DT	B-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
8/23/06	8/23/06	CD	B-NP	O
by	by	IN	B-PP	O
VERGIN	VERGIN	NN	B-NP	B-protein
,	,	,	O	O
MERLIN	MERLIN	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ZOCOR	ZOCOR	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
437553459	437553459	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/23/06	8/23/06	CD	B-NP	O
by	by	IN	B-PP	O
GUMZ	GUMZ	NN	B-NP	B-protein
,	,	,	O	O
KENNITH	KENNITH	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LEVOTHYROXINE	LEVOTHYROXINE	NN	B-NP	O
SODIUM	SODIUM	NN	I-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
164534476	164534476	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
NORVASC	NORVASC	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AMLODIPINE	AMLODIPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
3/9	3/9	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
HOLD	HOLD	NN	I-NP	B-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
110	110	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

METFORMIN	METFORMIN	NN	B-NP	O
500	500	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
Starting	Start	VBG	B-VP	O
when	when	WRB	B-ADVP	O
TOLERATING	TOLERATING	VBG	B-VP	B-protein
ADA	ADA	NNP	B-NP	I-protein
DIET	DIET	NNP	I-NP	I-protein
OXYCONTIN	OXYCONTIN	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
OXYCODONE	OXYCODONE	NNP	I-NP	I-protein
CONTROLLED	CONTROLLED	NNP	I-NP	I-protein
RELEASE	RELEASE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
10	10	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
Q12H	Q12H	NN	I-NP	I-protein
HYZAAR	HYZAAR	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	O
25	25	CD	I-NP	O
MG/100	MG/100	NN	I-NP	O
MG	MG	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
HYDROCHLORTHIAZIDE	HYDROCHLORTHIAZIDE	NN	I-NP	O
25M	25M	NN	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	IN	B-PP	O
AM	AM	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
3/9	3/9	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
HOLD	HOLD	NN	I-NP	B-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
110	110	CD	O	O
Number	Number	NNP	O	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
6	6	CD	B-NP	O
ACTOS	ACTOS	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
PIOGLITAZONE	PIOGLITAZONE	NN	I-NP	O
-RRB-	-RRB-	NNP	B-NP	O
15	15	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
when	when	WRB	B-ADVP	O
TOLERATING	TOLERATING	NNP	B-NP	O
ADA	ADA	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
May	May	MD	B-VP	O
be	be	VB	I-VP	O
taken	take	VBN	I-VP	O
without	without	IN	B-PP	O
regard	regard	NN	B-NP	O
to	to	TO	B-PP	O
meals	meal	NNS	B-NP	O
INSULIN	INSULIN	NN	I-NP	B-protein
NPH	NPH	NN	I-NP	I-protein
HUMAN	HUMAN	NN	I-NP	I-protein
42	42	CD	I-NP	I-protein
UNITS	UNITS	NNP	I-NP	I-protein
SC	SC	NNP	I-NP	I-protein
QAM	QAM	NNP	I-NP	I-protein
HOLD	HOLD	NNP	I-NP	I-protein
IF	IF	NNP	I-NP	I-protein
:	:	:	O	O
NPO	NPO	NNP	B-NP	O
FERROUS	FERROUS	NNP	I-NP	O
SULFATE	SULFATE	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
milk	milk	NN	I-NP	O
and	and	CC	I-NP	O
antacid	antacid	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
weight	weight	NN	B-NP	O
bear	bear	NN	I-NP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
with	with	IN	B-PP	O
UE	UE	NNP	B-NP	O
support	support	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr	Dr	NNP	B-NP	O
Emore	Emore	NNP	I-NP	O
4/27/06	4/27/06	CD	I-NP	O
Xray	Xray	NNP	I-NP	O
at	at	IN	B-PP	O
2	2	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
pm	pm	NN	I-NP	O
Appt	Appt	NN	I-NP	O
at	at	IN	B-PP	O
3	3	CD	B-NP	O
:	:	SYM	I-NP	O
00	00	CD	I-NP	O
pm	pm	NN	I-NP	O
3/25/06	3/25/06	CD	I-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
9/20/06	9/20/06	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
MONDAY/THURSDAY	MONDAY/THURSDAY	NN	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
CMH	CMH	NN	B-NP	O
Anticoagulation	Anticoagulation	NN	I-NP	O
service	service	NN	I-NP	O
,	,	,	O	O
316.629.1453	316.629.1453	CD	B-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
OA	OA	NNP	B-NP	O
Rt	Rt	NNP	I-NP	O
Knee	Knee	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
S/P	S/P	NNP	I-NP	O
Rt	Rt	NNP	I-NP	O
TKR	TKR	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
Osteoarthritis	Osteoarthritis	NNP	I-NP	O
,	,	,	O	O
Hypertension	Hypertension	NNP	B-NP	O
,	,	,	O	O
Diabuetes	Diabuetes	NNP	B-NP	O
Mellitus	Mellitus	NNP	I-NP	O
,	,	,	O	O
Hypothyroidism	Hypothyroidism	NNP	B-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
8/23/06	8/23/06	CD	B-NP	O
CLIMES	CLIMES	NNS	I-NP	O
,	,	,	O	O
SAM	SAM	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
RT	RT	NNP	I-NP	O
TKR	TKR	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
N/A	N/A	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
Rt	Rt	NN	I-NP	B-protein
TKR	TKR	NN	I-NP	I-protein
on	on	IN	B-PP	O
6/20/06	6/20/06	CD	B-NP	O
for	for	IN	B-PP	O
endstage	endstage	NN	B-NP	O
OA	OA	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
tolerated	tolerate	VBD	B-VP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
well	well	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
uncomplicated	uncomplicated	JJ	I-NP	O
post-operative	post-operative	JJ	I-NP	O
course	course	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
TKR	TKR	NN	I-NP	B-protein
pathway	pathway	NN	I-NP	O
with	with	IN	B-PP	O
exception	exception	NN	B-NP	O
of	of	IN	B-PP	O
post-op	post-op	JJ	B-NP	O
delerium	delerium	NN	I-NP	O
which	which	WDT	B-NP	O
required	require	VBD	B-VP	O
a	a	DT	B-NP	O
sitter	sitter	NN	I-NP	O
for	for	IN	B-PP	O
safety	safety	NN	B-NP	O
on	on	IN	B-PP	O
POD	POD	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

Patients	Patient	NNS	B-NP	O
MS	MS	NN	I-NP	O
gradually	gradually	RB	B-VP	O
improved	improve	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
baseline	baseline	NN	B-NP	O
by	by	IN	B-PP	O
POD	POD	NN	B-NP	B-protein
3	3	CD	I-NP	I-protein
,	,	,	O	O
at	at	IN	B-PP	O
which	which	WDT	B-NP	O
time	time	NN	I-NP	O
the	the	DT	B-NP	O
sitter	sitter	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
HD	HD	NN	B-NP	O
stable	stable	JJ	B-ADJP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
transfusion	transfusion	NN	I-NP	O
requirements	requirement	NNS	I-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

Hct	Hct	NN	B-NP	B-protein
was	be	VBD	B-VP	O
trending	trend	VBG	I-VP	O
up	up	RP	B-PRT	O
on	on	IN	B-PP	O
POD	POD	NN	B-NP	B-protein
4	4	CD	I-NP	I-protein
at	at	IN	B-PP	O
28.7	28.7	CD	B-NP	O
.	.	.	O	O

Standard	Standard	JJ	B-NP	O
care	care	NN	I-NP	O
with	with	IN	B-PP	O
PCEA	PCEA	NN	B-NP	B-protein
for	for	IN	B-PP	O
acute	acute	JJ	B-NP	O
pain	pain	NN	I-NP	O
management/CPM	management/CPM	NN	I-NP	O
,	,	,	O	O
prophylactic	prophylactic	JJ	B-NP	O
IV	IV	CD	I-NP	O
abx	abx	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Coumadin/TEDS/P-boots	Coumadin/TEDS/P-boot	NNS	B-NP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
mobilized	mobilize	VBD	B-VP	O
OOB	OOB	NN	B-NP	B-protein
with	with	IN	B-PP	O
PT	PT	NN	B-NP	B-protein
WBAT	WBAT	NN	I-NP	I-protein
.	.	.	O	O

Refer	Refer	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
page	page	NN	I-NP	O
3	3	CD	I-NP	O
for	for	IN	B-PP	O
ROM/functional	ROM/functional	JJ	B-NP	B-cell_type
details	detail	NNS	I-NP	I-cell_type
.	.	.	O	O

Wound	Wound	JJ	B-NP	O
clean	clean	JJ	I-NP	O
and	and	CC	O	O
healing	heal	VBG	B-VP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
stable	stable	JJ	B-ADJP	O
for	for	IN	B-PP	O
transfer	transfer	NN	B-NP	O
to	to	TO	B-VP	O
rehab	rehab	VB	I-VP	O
on	on	IN	B-PP	O
POD	POD	NN	B-NP	B-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
DSD	DSD	NN	B-NP	O
qd	qd	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
wound	wound	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
left	leave	VBN	I-VP	O
OTA	OTA	NNP	B-NP	O
when	when	WRB	B-ADVP	O
dry	dry	JJ	B-ADJP	O
.	.	.	O	O

Staples	Staple	NNS	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
removed	remove	VBN	I-VP	O
in	in	IN	B-PP	O
rehab	rehab	NN	B-NP	O
or	or	CC	B-PP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
VNA	VNA	NN	I-NP	B-protein
as	as	IN	B-PP	O
of	of	IN	B-PP	O
2/30/06	2/30/06	CD	B-NP	O
,	,	,	O	O
please	please	VB	B-INTJ	O
sterristrip	sterristrip	VB	B-VP	O
the	the	DT	B-NP	O
wound	wound	NN	I-NP	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
TEDS	TEDS	NN	I-NP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
arrange	arrange	NN	B-NP	O
blood	blood	NN	I-NP	O
draws	draw	NNS	I-NP	O
for	for	IN	B-PP	O
PT/INR	PT/INR	NN	B-NP	B-protein
q	q	NN	I-NP	O
Mon/Thurs	Mon/Thur	NNS	I-NP	O
with	with	IN	B-PP	O
results	result	NNS	B-NP	O
called	call	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
AHC	AHC	NNP	I-NP	O
Anticoagulation	Anticoagulation	NNP	I-NP	O
Service	Service	NNP	I-NP	O
uk349-114-7420	uk349-114-7420	NN	I-NP	O
hgn	hgn	NN	I-NP	O
9	9	CD	I-NP	O
for	for	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

Goal	Goal	NNP	B-NP	O
INR	INR	NNP	I-NP	O
is	be	VBZ	B-VP	O
1.5-2	1.5-2	CD	B-NP	O
.5	.5	CD	I-NP	O
;	;	:	O	O
DVT	DVT	NN	B-NP	O
prophyalxis	prophyalxis	NN	I-NP	O
is	be	VBZ	B-VP	O
planned	plan	VBN	I-VP	O
X	X	SYM	B-NP	O
3	3	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Any	Any	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
issues	issue	NNS	I-NP	O
or	or	CC	O	O
action	action	NN	B-NP	O
values	value	NNS	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
called	call	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Anticoagulation	Anticoagulation	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
Arrange	Arrange	NN	B-NP	O
blood	blood	NN	I-NP	O
draws	draw	NNS	I-NP	O
for	for	IN	B-PP	O
PT/INR	PT/INR	NN	B-NP	B-protein
q	q	NN	I-NP	O
Mon/Thurs	Mon/Thur	NNS	I-NP	O
with	with	IN	B-PP	O
results	result	NNS	B-NP	O
called	call	VBN	B-VP	O
to	to	TO	B-PP	O
583-443-9773	583-443-9773	CD	B-NP	O
oxq	oxq	NN	I-NP	O
9	9	CD	I-NP	O
for	for	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
management	management	NN	I-NP	O
NOTIFY	NOTIFY	NN	I-NP	O
the	the	DT	B-NP	O
Anticoagulation	Anticoagulation	NNP	I-NP	O
Service	Service	NNP	I-NP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-NP	O
Staple	Staple	NN	I-NP	O
removal	removal	NN	I-NP	O
7/27/06	7/27/06	CD	I-NP	O
Follow	Follow	NNP	I-NP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr	Dr	NNP	B-NP	O
Jantz	Jantz	NNP	I-NP	O
as	as	IN	B-SBAR	O
scheduled	schedule	VBN	B-NP	O
No	No	DT	I-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
EARENFIGHT	EARENFIGHT	NN	B-NP	O
,	,	,	O	O
LEOPOLDO	LEOPOLDO	NN	B-NP	B-protein
,	,	,	O	O
PA-C	PA-C	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
MT72	MT72	NN	I-NP	O
-RRB-	-RRB-	SYM	B-NP	O
3/6/06	3/6/06	CD	B-NP	O
@	@	SYM	I-NP	O
12	12	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

